FORJ MEDICAL

What this means for you

Not registered yet, but its 05 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99377245

Mark type

Stylized text

Filed

05 Sept 2025

Published for opposition

21 Jul 2026

Attorney of record

J. Matthew Pritchard

Goods and services

• Class 010 — Medical apparatus: Medical devices, apparatus, and components thereof, for use in wearable medical devices, namely, continuous glucose monitors and transdermal microneedles; medical devices, apparatus, and components thereof, for use in medical fluid and gas management, namely, cryoablation, life support, patient thermal management, organ transplant, in-vitro diagnostics, infusion therapy and biofluid purification; medical devices, apparatus, and components thereof, for use in medical visualization systems, namely, optics, illumination and multi-spectral imaging, endoscopy, medical topography and tomography, intravascular and external ultrasound, retinal scanning and imaging, pulse oximetry, surgical navigation, optical diagnostics, and medical robotics; surgical devices and instruments in the nature of surgical energy systems, namely, radio frequency and microwave ablation, electrosurgery, in-vivo electroporation, and therapeutic ultrasound; medical devices, apparatus, and components thereof, for use in medical stimulation and monitoring, namely, mechanical, electrical, magnetic and optical stimulation, and cardiac rhythm management; surgical devices and instruments in the nature of surgical navigation systems, namely, electromagnetic navigation consoles, sensors, and field generators; surgical devices and instruments in the nature of surgical consumables, namely, micro, aspiration, infusion, access and balloon catheters, surgical access sheaths, and braided, coiled and steerable surgical shafts and catheters
• Class 040 — Treatment of materials: Custom manufacturing of medical devices and their components for use in wearable medical devices namely continuous glucose monitors and transdermal microneedles; custom manufacturing of medical devices and their components for use in medical fluid and gas management, namely, cryoablation, life support, patient thermal management, organ transplant, in-vitro diagnostics, infusion therapy and biofluid purification; custom manufacturing of medical devices and their components for use in medical visualization systems, namely, optics, illumination and multi-spectral imaging, endoscopy, medical topography and tomography, intravascular and external ultrasound, retinal scanning and imaging, pulse oximetry, surgical navigation, optical diagnostics, and medical robotics; custom manufacturing of medical devices and their components for use in surgical energy systems, namely, radio frequency and microwave ablation, electrosurgery, in-vivo electroporation, and therapeutic ultrasound; custom manufacturing of medical devices and their components for use in medical stimulation and monitoring, namely, mechanical, electrical, magnetic and optical stimulation, and cardiac rhythm management; custom manufacturing of medical devices and their components for use in surgical navigation systems, namely, electromagnetic navigation consoles, sensors, and field generators; Custom manufacturing of medical and surgical consumables, namely, micro, aspiration, infusion, access and balloon catheters, surgical access sheaths, and braided, coiled and steerable surgical shafts and catheters; Manufacturing services for others in the field of medical devices for use in medical fluid and gas management, namely, cryoablation, life support, patient thermal management, organ transplant, in-vitro diagnostics, infusion therapy and biofluid purification; manufacturing services for others in the field of medical devices, in the nature of medical optical systems, namely, visualization, illumination and multi-spectral imaging, endoscopy, medical topography and tomography, intravascular ultrasound, retinal scanning and imaging, pulse oximetry, surgical navigation, optical diagnostics, and medical robotics; manufacturing services for others in the field of medical devices, in the nature of surgical energy systems, namely, radio frequency and microwave ablation, electrosurgery, in-vivo electroporation, and therapeutic ultrasound; manufacturing services for others in the field of medical devices, in the nature of medical stimulation and monitoring, namely, mechanical, electrical, magnetic and optical stimulation, and cardiac rhythm management; manufacturing services for others in the field of medical devices, in the nature of surgical navigation systems, namely, electromagnetic navigation consoles, sensors, and field generators; Manufacturing services for others in the field of medical and surgical consumables, namely, micro, aspiration, and balloon catheters, surgical access sheaths, and braided, coiled and steerable surgical shafts
• Class 042 — Scientific and technological services: Design and development of digital hardware components for others for use in industrial and medical applications, namely, software development and engineering, custom design of prototypes, and industrial design of electromechanical devices and components

Owner

• Intricon Corporation, Arden Hills, MN, US
• Intricon Corporation, Arden Hills, MN, US

Prosecution history

• 19 Aug 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
• 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 21 Jul 2026 — PUBLISHED FOR OPPOSITION
• 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 23 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
• 23 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
• 23 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
• 08 Jun 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 08 Jun 2026 — FINAL REFUSAL E-MAILED
• 08 Jun 2026 — FINAL REFUSAL WRITTEN
• 27 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED